Rapid intravenous infusion of amphotericin B: A pilot study
The American Journal of MedicinePublished 1 August 1992
Julia M. Cruz, James E. Peacock, Lance Loomer, Larry W. Holder, Gregory W. Evans, Bayard L. Powell
Citations48
SJR quartileQ1
SJR score1.00
SNIP1.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Rapid infusions of amphotericin B are safe, are associated with similar toxicity as prolonged infusions, and facilitate inpatient care by decreasing nursing time needed for administration and minimizing scheduling conflicts with other necessary intravenous medications.
Abstract
Rapid infusions of amphotericin B are safe, are associated with similar toxicity as prolonged infusions, and facilitate inpatient care by decreasing nursing time needed for administration and minimizing scheduling conflicts with other necessary intravenous medications. Shorter infusions also facilitate outpatient and home administration of amphotericin B.
Keywords
MedicinePharmacology, Toxicology and Pharmaceutics
Annals of Internal MedicinePrinciples and Practice of Infectious Diseases.
12,102 Citations1991
This updated and expanded edition now offers 297 chapters that cover the basic principles of diagnosis and management, major clinical syndromes, all important pathogenic microbes and the diseases they cause, plus a number of specialised topics useful to the practitioner.
Clinical Infectious DiseasesAmphotericin B: 30 Years of Clinical Experience
1,005 Citations1990Harry A. Gallis, Richard H. Drew +1 more
The clinical uses of amphotericin B are discussed, including its application in AIDS-related fungal infections, in neutropenic cancer patients who are persistently febrile, and in infections of the central nervous system, lung, peritoneum, genitourinary system, eye, and skin.
Archives of Internal MedicineCurrent Clinical Topics in Infectious Diseases
473 Citations1984
This work discusses nonmenstrual Toxic Shock Syndrome, human Immunodeficiency Virus Type 2: Human Biology of the Other AIDS Virus, and novel Plasmid-mediated B-Lactamases in Enterobacteriaceae: Emerging Problems for New B-lactam Antibiotics.
New England Journal of MedicineStrategies in the Treatment of Systemic Fungal Infections
344 Citations1980Gerald Medoff, George S. Kobayashi
In the past few years, there has been an increase in the number of systemic fungal infections seen in clinical practice, and those due to primary pathogens such as MRSA and Clostridium difficile have been of two types.
Clinical Approach to Infection in the Compromised Host
337 Citations1995Robert H. Rubin, Lowell S. Young
Annals of Internal MedicineNephrotoxicity of Amphotericin B
330 Citations1964William T. Butler, JOHN E. BENNETT +4 more
The American Journal of MedicineAmphotericin B-resistant yeast infection in severely immunocompromised patients
233 Citations1988William G. Powderly, George S. Kobayashi +2 more
It is concluded that yeast fungemia in severely immunocompromised patients is often caused by organisms resistant to the usual concentrations of amphotericin B obtainable in vivo, and that this finding is clinically significant.
New England Journal of MedicineRenal Tubular Acidosis Due to Amphotericin B
208 Citations1968Donna K. McCurdy, Myron W. Frederic +1 more
Nephrotoxicity, the major complication of long-term therapy with amphotericin B, is attributed to drug-induced renal vasoconstriction plus a direct toxic action on renal tubules.
The American Journal of MedicineNephrotoxicity of amphotericin B, with emphasis on changes in tubular function
167 Citations1972Janis L. Burgess, Robert Birchall
The most consistent change in proximal tubular function was an increase in the clearance of uric acid which rose with increasing dosage of amphotericin B and varied inversely with the glomerular filtration rate.
Mayo Clinic ProceedingsAntifungal Agents Used for Deep-Seated Mycotic Infections
153 Citations1992Christine L. Terrell, Carolyn E. Hughes
The main emphasis in this paper is on the broad-spectrum antifungal agent amphotericin B and the narrow-spectrums agent flucytosine and the number of newer agents and combinations of drugs warrant mention, but clinical experience is limited and these agents or combinations have not been approved for clinical use.
The American Journal of MedicineRisk factors for amphotericin B-associated nephrotoxicity
127 Citations1989Melanie Fisher, George H. Talbot +4 more
Risk factors for amphotericin B-associated nephrotoxicity include higher average daily doses, diuretic use, and abnormal baseline renal function, which suggest possible protective interventions and will aid clinicians in assessing the risk-benefit ratio of amphoteric in B therapy for deep fungal infection.
The American Journal of MedicineRenal magnesium wasting associated with amphotericin B therapy
124 Citations1984Cyril H. Barton, Madeleine V. Pahl +2 more
The American Journal of MedicineCoccidioidomycosis and its treatment with amphotericin B
114 Citations1958M. L. Littman, Phillip L. Horowitz +1 more
Drug Intelligence & Clinical PharmacyA Review of Complications of Amphotericin-B Therapy: Recommendations for Prevention and Management
112 Citations1980Michael S. Maddux, Steven L. Barriere
Various types of nephrotoxicity, thrombophlebitis, and anemia are described along with suggestions for their prevention and management, along with a commentary on allergic reactions.
PubMedFungal infections in the immunocompromised host.
109 Citations1984Carolyn Hawkins, Donald Armstrong
Specific areas of current research include serological assays for fungal antigens and metabolites which may allow earlier diagnosis, treatment with combinations of antifungal agents, and the development of new antifailal agents.
The Journal of Infectious DiseasesInduction of Prostaglandin Synthesis as the Mechanism Responsible for the Chills and Fever Produced by Infusing Amphotericin B
104 Citations1987F Gigliotti, J. L. Shenep +2 more
It is postulate that the chills and fever produced by an infusion of amphotericin B are mediated through prostaglandin E2 synthesis, and ibuprofen is therapeutically useful in ameliorating the ch Chill reactions considered severe.
Archives of Internal MedicineExperience with Amphotericin B for the Treatment of Systemic Mycoses
85 Citations1958John H. Seabury
In vitro sensitivities of the major producers of deep mycotic infection in man as determined by various investigators are contained in the Table.
Clinical Infectious DiseasesEvolution of Antifungal Agents: Past, Present, and Future
84 Citations1987E. Drouhet, B. Dupont
The association of immunotherapy with antifungal chemotherapy may offer new treatments for fungal infections in immunocompromised patients and future trends for the development of agents with fungicidal activity, wider spectra, and better distribution are proposed.
PubMedAmphotericin B revisited: reassessment of toxicity.
80 Citations1990Clements Js, Peacock Je
Although clinically important toxicities continue to occur with usage of amphotericin B despite current methods of infusion and premedication, these are usually manageable and rarely limit the course of therapy.
Clinics in HaematologyFungal Infections in the Immunocompromised Host CATHERINE HAWKINS
72 Citations1984Donald Armstrong
Antimicrobial Agents and ChemotherapyRisk factors of ventricular fibrillation during rapid amphotericin B infusion
71 Citations1985Philip C. Craven, David H. Gremillion
Prolonged infusion (3 h) and concurrent hemodialysis each prevented the development of hyperkalemia and ventricular arrhythmia and it is recommended that rapid infusion of amphotericin B not be used in patients with impaired potassium excretion unless accompanied by he modialysis and careful potassium monitoring.
Mayo Clinic ProceedingsAntifungal Agents Used for Deep-Seated Mycotic Infections
53 Citations1987Christine L. Terrell, Paul E. Hermans
For the treatment of cryptococcal meningitis, the current recommendation is for the combined use of amphotericin B and flucytosine, and 2-Hydroxystilbamidine is used only in indolent cases of blastomycosis; however, this condition is usually treated with amphoteric in B.
Fungal Infections in the Compromised Host
49 Citations1988Françoise Meunier
The difference between fungal infection in the impaired host as opposed to the normal individual is strikingly demonstrated by a study from California that compared the types ofFungal infection observed in different patient populations.
Applied MicrobiologyEffect of Rapid Intravenous Infusion on Serum Concentrations of Amphotericin B
40 Citations1971Branch T. Fields, Joseph H. Bates +1 more
Although rapid infusions caused no more toxicity than did slow infusions, the lack of greater toxicity with rapid infusion of amphotericin B should be further documented prior to extensive clinical application of this procedure.
Applied MicrobiologyEffect of Rapid Intravenous Infusion on Serum Concentrations of Amphotericin B 1
26 Citations1971Branch T. Fields, Joseph H. Bates +1 more
Archives of Internal MedicinePrevention of Amphotericin B—Induced Rigors by Dantrolene
24 Citations1986Mark H. Gross
Observations suggest that dantrolene is useful as an alternative or adjuvant agent for severe rigors associated with amphotericin 3 infusion.
PubMedAmphotericin B nephrotoxicity.
13 Citations1988Raymond Raymond
Nephrotoxicity becomes apparent days to months after the institution of amphotericin B therapy, characterized by azotemia, decreased renal plasma flow, decreased glomerular filtration rate, tubular defects, nephrocalcinosis, and diffuse, nonspecific histologic changes.
Infection ControlAmphotericin—How Safe and Effective?
5 Citations1985Sandra M. Norris
Over a period of 35 days beginning July 23, 1984, the Infection Control Section of the Nassau Hospital, a 535-bed community teaching institution received reports of an unusually high number of PPD tuberculin skin test conversions among employees from Employee Health Service personnel.
PubMedTherapy of fungal infections.
3 Citations1982Drutz Dj
For all its many problems, amphotericin B cannot be faulted on the basis of easy acquisition of drug resistance, and remains quite rare, although there are case reports of its occurrence under conditions of immunosuppression.